Eisai shares fall following report of patient death in Alzheimer’s trial By: MarketWatch November 28, 2022 at 21:49 PM EST Eisai Co.'s shares fell Tuesday following a report that a woman died after receiving the company's experimental Alzheimer's drug. Read More >> Related Stocks: Biogen Idec
